These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
344 related articles for article (PubMed ID: 17067225)
1. [Waldemström s macroglobulinemia]. Khosravi Shahi P; del Castillo Rueda A; Díaz Muñoz de la Espada VM An Med Interna; 2006 Jun; 23(6):291-3. PubMed ID: 17067225 [TBL] [Abstract][Full Text] [Related]
2. Treatment recommendations in Waldenstrom's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia. Gertz MA; Anagnostopoulos A; Anderson K; Branagan AR; Coleman M; Frankel SR; Giralt S; Levine T; Munshi N; Pestronk A; Rajkumar V; Treon SP Semin Oncol; 2003 Apr; 30(2):121-6. PubMed ID: 12720120 [TBL] [Abstract][Full Text] [Related]
3. Waldenström's macroglobulinemia. Dimopoulos MA; Anagnostopoulos A Best Pract Res Clin Haematol; 2005; 18(4):747-65. PubMed ID: 16026748 [TBL] [Abstract][Full Text] [Related]
13. [The treatment of Waldenström macroglobulinemia and the therapy of diseases caused by monoclonal IgM gammaglobulin]. Adam Z; Scudla V; Krejcí M; Korístek Z Vnitr Lek; 2008 Jan; 54(1):68-83. PubMed ID: 18390120 [TBL] [Abstract][Full Text] [Related]
18. Waldenström's macroglobulinemia. An overview of its clinical, biochemical, immunological and therapeutic features and our series of 121 patients collected in a single center. Merchionne F; Procaccio P; Dammacco F Crit Rev Oncol Hematol; 2011 Oct; 80(1):87-99. PubMed ID: 21036057 [TBL] [Abstract][Full Text] [Related]
19. Rituximab-based treatments in Waldenström's macroglobulinemia. Dimopoulos MA; Kastritis E; Roussou M; Eleutherakis-Papaiakovou E; Migkou M; Gavriatopoulou M; Tassidou A; Terpos E Clin Lymphoma Myeloma; 2009 Mar; 9(1):59-61. PubMed ID: 19362975 [TBL] [Abstract][Full Text] [Related]